| SUNNYVALE, Calif., Feb. 23, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing MANF, a first-in-class disease–modifying therapeutic protein, today announced that Gerald E. Commissiong, President and CEO, will present the Company's updated business plan at the 2012 National Investment Banking Association (NIBA) conference on Thursday, February 23, 2012 at 12:25pm CST at Le Pavillon Hotel in New Orleans, LA. Mr. Commissiong will also be hold...continued AMBS |
Thursday, February 23, 2012
Amarantus BioSciences to Present at the 2012 National Investment Banking Association Conference in New Orleans
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment